RSSLetters to the Editor

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

Letter to the Editor: Discussing ANT1 role in Amyotrophic Lateral Sclerosis pathogenesis

| April 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a rapid progression, affecting motor neurons in the brain and spinal cord, ultimately leading to respiratory failure and death.1 ALS might present as sporadic (sALS) or familial (fALS), both of which are clinically indistinguishable.1 ALS etiology is still unknown, despite […]

Continue Reading

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

Letter to the Editor: Olanzapine and Diabetic Ketoacidosis: What is the Underlying Mechanism?

| April 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Recently, Iwaku et al1 reported a detailed case of olanzapine-related acute-onset Type 1 diabetes with ketoacidosis.1 They concluded that olanzapine sometimes can cause sudden hyperglycemia that results in precipitating the onset of Type 1 diabetes. In fact, there is no report of olanzapine-induced diabetes with immunological mechanism. We reported […]

Continue Reading

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

Letter to the Editor: Prolactin levels in Patients with Schizophrenia who were switched from daily to once-monthly Aripiprazole treatment

| April 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(3–4):11–14 Dear Editor: Schizophrenia is a chronic and progressive psychiatric disorder requiring long-term treatment with antipsychotics. The use of long-acting injectable antipsychotics (LAI) has been shown to increase adherence, reduce risk of relapse, and support recovery for patients with schizophrenia by achieving an optimal dopamine (D)2 receptor occupancy.1 Among several oral antipsychotics, […]

Continue Reading

Letter to the Editor: Pneumocephalus: Is the needle size  significant?

Letter to the Editor: Pneumocephalus: Is the needle size significant?

| February 1, 2018 | 0 Comments

Continue Reading

Letter to the editor: Marijuana on the brain— a concern

Letter to the editor: Marijuana on the brain— a concern

| February 1, 2018 | 0 Comments

Continue Reading

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

Letter to the editor: Stroke Telerehabilitation in Sicily: a cost-effective approach to reduce disability?

| February 1, 2018 | 0 Comments

Continue Reading

An Open-Label Prophylaxis Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) Combination for Rapid Cycling Bipolar Disorder

An Open-Label Prophylaxis Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) Combination for Rapid Cycling Bipolar Disorder

| September 1, 2017 | 0 Comments

by Sriram Ramaswamy, MD; David Driscoll, PhD; and Lynette M. Smith, PhD Dr. Ramaswamy is with the Department of Psychiatry, Creighton University School of Medicine, Omaha, Nebraska, and the VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska. Dr. Driscoll is with the VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska. Dr. Smith is with the […]

Continue Reading

Letters to the Editor: Discussing sexual health after traumatic brain injury: an unmet need!

Letters to the Editor: Discussing sexual health after traumatic brain injury: an unmet need!

| February 1, 2017 | 0 Comments

Innov Clin Neurosci. 2017;14(1–2):11–12

Continue Reading